InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-07-10 | Daniel Goldman(D-NY10) | house | Sale | $1,001 - $15,000 |
No financial data available for MKKGY.
Company may not file with SEC or CIK is unresolved.
How The Merck KGaA (XTRA:MRK) Investment Story Is Shifting As Analysts Reset Expectations
Merck KGaA AGM: CEO Garijo’s final address, stable €2.20 dividend, Beckmann to take over May 1
Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Merck KGaA and Remepy join forces to develop combo drug-digital therapies
Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas
Merck KGaA: Small Breakout In 2026, Followed By Normalization
Here's What We Like About Merck KGaA's (ETR:MRK) Upcoming Dividend
Inhibrx cancer drug reportedly drawing interest of Merck and rivals
$10+ Bn Microbiology Testing Market Analysis by Product, Technology, End User - Global Forecast to 2031
Merck KGaA (MKKGY) Presents at BNP Paribas Exane Healthcare Conference - Slideshow
Merck KGaA: Diversified Innovation At An Attractive Valuation